Adjuvant immunotherapy with nonviable mycobacterium smegmatis in resected primary lung carcinoma a randomized clinical trial of 219 patients
✍ Scribed by Guy Decroix; Claude Chastang; Dominique Fichet; Bernard Asselain; Bernard Lebeau; Vincent Morice; Thierry Lepage; Pierre Babo; Chantal Fabre; Jean-Louis Rebischung; Jean-Louis Accard; Georges Hinault; Joseph Sauvaget; Jacques Rochemaure; Claude Soubrane; Michel Jagueux; Lucien Toty; Paul Herzog; Philippe Daumet; Jacques Grosset; François Gremy
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 603 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND To the authors' knowledge, the significance of postoperative adjuvant chemotherapy in pancreaticobiliary carcinoma has not yet been clarified. A randomized controlled study evaluated the effect of postoperative adjuvant therapy with mitomycin C (MMC) and 5‐fluorouracil (5